Sanjay Bhanot - Department of Antisense Drug Discovery, Isis Pharmaceuticals, Inc

基本信息

浏览量：100

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 248 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

AZD2693, a PNPLA3 Antisense Oligonucleotide, for the Treatment of MASH in 148M Homozygous Participants: Two Randomized Phase I Trials

Javier Armisen, Mitra Rauschecker,Janeli Sarv,Mathias Liljeblad,Linda Wernevik, Mohammad Niazi,Jane Knöchel, Olof Eklund, Therése Sandell, James Sherwood,Linnéa Bergenholm, Stefan Hallén, Shan Wang, Prasad Kamble, Maria Bhat, Ingela Maxvall, Yixin Wang,Richard G. Lee,Sanjay Bhanot,Shuling Guo

Journal of Hepatology (2025)

引用0浏览0WOS引用

GS-012 Novel DGAT2 Antisense Inhibitor Demonstrates Significant MASH Resolution in Biopsy-Proven F2/F3 MASH: Results from a 51-Week Multicenter Randomized Double-Blind Placebo-Controlled Phase 2 Trial

Rohit Loomba,Erin Morgan, Keyvan Yousefi, Dan Li,Richard Geary,Sanjay Bhanot

Journal of Hepatology (2024): S7

引用0浏览0引用

Novel DGAT2 Antisense Inhibitor Demonstrates Significant MASH Resolution in Biopsy-Proven F2/F3 MASH: Results from a 51-Week Multicenter Randomized Double-Blind Placebo-Controlled Phase 2 Trial

Rohit Loomba,Erin Morgan, Keyvan Yousefi, Dan Li,Richard Geary,Sanjay Bhanot

JOURNAL OF HEPATOLOGY (2024): S7-S7

引用0浏览0引用

AZD2693, a Potent PNPLA3 Antisense Oligonucleotide, Decreases Hepatic PNPLA3 Mrna and Liver Fat Content in Participants with Presumed MASHand Homozygous for the PNPLA3148M Risk Allele

Javier Armisen, Mitra Rauschecker,Janeli Sarv,Mathias Liljeblad, Mohammad Niazi,Oskar Clewe, Olof Eklund, Therese Sandell,Daniel Linden, Stefan Hallen,Linda Wernevik, Sofia Koster, Erika Morizzo, Jeanna Sundelin,Bjorn Carlsson, Lars Hansen,Jane Knochel,Sanjay Bhanot,Shuling Guo,Ola Fjellstrom,Jenny Blau,Rohit Loomba

JOURNAL OF HEPATOLOGY (2024): S93-S93

引用0浏览0引用

Safety and Tolerability of GalNAc3-Conjugated Antisense Drugs Compared to the Same-Sequence 2′-O-methoxyethyl-modified Antisense Drugs: Results from an Integrated Assessment of Phase 1 Clinical Trial Data

Brenda F. Baker,Shuting Xia,Wesley Partridge,Jeffery A. Engelhardt,Sotirios Tsimikas,Stanley T. Crooke,Sanjay Bhanot,Richard S. Geary

NUCLEIC ACID THERAPEUTICS（2024）

引用1浏览0WOS引用

NOVEL DGAT2 ANTISENSE INHIBITOR DEMONSTRATES SIGNIFICANT HISTOLOGICAL BENEFIT IN BIOPSY-PROVEN MASH PATIENTS WITH ADVANCED LIVER FIBROSIS STAGE F3: SUBSET ANALYSIS OF A 51-WEEK MULTICENTER RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE 2 TRIAL

Rohit Loomba,Erin Morgan, Keyvan Yousefi, Dan Li,Richard Geary,Sanjay Bhanot

HEPATOLOGY (2024): S1868-S1869

引用0浏览0引用

LBP-031 AZD2693, a Potent PNPLA3 Antisense Oligonucleotide, Decreases Hepatic PNPLA3 Mrna and Liver Fat Content in Participants with Presumed MASH and Homozygous for the PNPLA3148M Risk Allele

Javier Armisen, Mitra Rauschecker,Janeli Sarv,Mathias Liljeblad, Mohammad Niazi,Oskar Clewe, Olof Eklund, Therese Sandell,Daniel Linden, Stefan Hallen,Linda Wernevik, Sofia Köster, Erika Morizzo, Jeanna Sundelin,Björn Carlsson, Lars Hansen,Jane Knöchel,Sanjay Bhanot,Shuling Guo,Ola Fjellstrom

Journal of Hepatology (2024): S93

引用0浏览0引用

Assessment of the Effect of Organ Impairment on the Pharmacokinetics of 2′‐MOE and Phosphorothioate Modified Antisense Oligonucleotides

Yanfeng Wang,John K. Diep,Rosie Z. Yu,Eunju Hurh,Ewa Karwatowska-Prokopczuk,Eugene Schneider,Scott Henry,Sanjay Bhanot,Richard S. Geary

JOURNAL OF CLINICAL PHARMACOLOGY（2023）

引用2浏览0WOS引用

OR27-4 Placebo-Controlled and Open-Label Extension Study of a Novel Hepatic-Targeted Antisense Cimdelirsen (Ionis-Ghr-lrx) under Investigation in Acromegaly Patients

Sanjay Bhanot,Maria Fleseriu,Richard Geary, Kuolung Hu, Lu Li,Shlomo Melmed, Julia Trunfio, Elaine Waldman,Erin Morgan

Journal of the Endocrine Societyno. Supplement_1 (2022)

引用2浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn